Navigation Links
Rib-X Pharmaceuticals, Inc. Appoints Dr. Russell Greig to Board of Directors
Date:6/30/2009

NEW HAVEN, Conn., June 30 /PRNewswire/ -- Rib-X Pharmaceuticals, Inc., a development stage company focused on the discovery and development of novel antibiotics for the treatment of antibiotic resistant infections, announced today that Russell Greig, Ph.D., of SR One venture capital, has been appointed to the Company's Board of Directors. Rib-X's board now consists of eleven members.

"We are extremely pleased that Russell Greig has joined the Rib-X Board of Directors," said Dr. Susan Froshauer, President and Chief Executive Officer, Rib-X. "Russell brings an impressive mix of both R&D and business development experience that will be crucial as the Company grows and continues to move products through the development pipeline."

Russell Greig is President of SR One, the venture capital arm of GlaxoSmithKline (GSK). Prior to joining SR One, he served as President of GSK's Pharmaceuticals International from 2003 to 2008, and also served on the GSK Corporate Executive Team. Dr. Greig originally joined GSK (then SmithKline & French) in 1980 in the Departments of Tumor and Cell Biology. In 1991, following the merger with Beecham, he was appointed Vice President, Project Management. From 1993 to 1996, he served as Vice President and Director of Advanced Technologies in Genetics with special responsibility for managing collaborations with The Institute of Genomic Research and Human Genome Sciences. In 1996 Dr. Greig joined SmithKline Beecham's European Pharmaceutical Operations as Vice President and Director of European Market Development, and was later appointed Managing Director and General Manager of SmithKline Beecham's UK Pharmaceuticals. Following the merger of SmithKline Beecham with Glaxo Wellcome in 2000, he returned to the United States as Senior Vice President for Worldwide Business Development.

Dr. Greig also serves on the boards of Genocea Biosciences and the Edinburgh BioQuarter Commerci
'/>"/>

SOURCE Rib-X Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Rib-X Pharmaceuticals Announces Presentations at the 19th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)
2. Rib-X Pharmaceuticals Announces Positive Phase 2 Study Results for Delafloxacin and a $25 Million Financing
3. Rib-X Pharmaceuticals to Present at the 2008 ICAAC/IDSA Joint Meeting
4. Rib-X Pharmaceuticals, Inc. Announces Formation of Clinical Advisory Board
5. Rib-X Pharmaceuticals to Present at Cambridge Healthtech Institutes 2nd Annual Challenge of Antibacterial Development Conference
6. Rib-X Pharmaceuticals Initiates Two Phase 2 Studies for Novel Antibiotic Compound RX-1741
7. Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program
8. Anadys Pharmaceuticals, Inc. Announces Strategic Restructuring to Focus Operations on Continuing the Advancement of ANA598
9. Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009
10. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on First Quarter 2009 Financial Results on Thursday, May 14, 2009 at 8:30am EDT
11. Angiotech Pharmaceuticals, Inc. announces financial results for the first quarter ended March 31, 2009

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009).... 1 /PRNewswire-Asia/ -- Shanghai ChemPartner, as ...China-based Contract Research,Organization (CRO), ...e,Technology Fast 50 China, ranking 3rd on the lis...ina. The award is a testament to ChemPartner,s out...08. , The results of the 2009 Deloitte Te...
(Date:12/1/2009)...l., Dec. 1 Prairie Heart Institute...was recently awarded two statuettes at the first-e... York City. The CLIO Healthcare Awards recognizes ...re advertising industry and is an extension of the...wards competitions for advertising, design and int...
(Date:12/1/2009)...rprise level storage is now available to small and...ng the bank. , (PRWEB) De....com ), a medical imaging software company, annou...torage service. The PacsDrive service enables smal...ly archive medical imaging in compliance with HIPA...
(Date:12/1/2009)...ruent Software agrees to migrate their Microsoft D...lients) to Synergy Business Solutions to maintain ...e, WA (PRWEB) December 1, 2009 -- Synergy Business...rosoft Dynamics SL practice of Congruent Software,...move was necessary due to a change in Congruent So...
Breaking Biology Technology:Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 2Shanghai ChemPartner Ranks 3rd among 2009 Deloitte Technology Fast 50 China Winning Companies 3Prairie Heart Institute of Illinois Wins Two CLIO Healthcare Awards 2PacsDrive Announces Low Cost Medical Imaging Storage Service, Seeks to Alter Status Quo in Health Care IT 2Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc. 2Synergy Business Solutions Acquires the Microsoft Dynamics SL Practice of Congruent Software, Inc. 3
...008 Cardiac Science,Corporation (Nasdaq: CSCX ),...uscitation, rehabilitation, and informatics produc... Australian Defence Force for the initial supply,o...efibrillators (AEDs) and,accessories. The sale add...0-unit delivery to Eastern European military force...
...pkins researchers has solved important puzzles con...n of bacteria, discoveries that could lead to a ne...hed in the journal Current Biology, the scientists...g, which pinches a rod-shaped bacterium to produce...d MinC. By exploiting this vulnerability, the rese...
...pril 8, 2008 HemoGenix(R),Inc., a privately-held ...ported that the USPTO has issued the first two of ...(R) technology. HALO(R) is the 21st,century answer... the,traditional colony-forming cell (CFC) assay, ...nd validated by HemoGenix(R) with the help of a,SB...
Other Biology Technology:Australia Chooses Cardiac Science to Equip Its Defence Force 2Australia Chooses Cardiac Science to Equip Its Defence Force 3Solving the Z ring's mysteries may lead to new antibiotics 2Solving the Z ring's mysteries may lead to new antibiotics 3HemoGenix(R), Inc. Receives Issued Patent for its HALO(R) Technology Platform From the United States Patent and Trademark Office (USPTO). 2HemoGenix(R), Inc. Receives Issued Patent for its HALO(R) Technology Platform From the United States Patent and Trademark Office (USPTO). 3
(Date:12/1/2009)... the 2009 Inserm Grand Prix., Every year since 2...tribute to outstanding,work performed in its labo...serm intends to,demonstrate the diversity and wea...medical and,health research, and the creativity a...,drive this research each day. The Inserm 2009 pri...
(Date:12/1/2009)...1 iQor, a global provider of busin...ed in the 2009 InfoWorld 100 Awards Top 100 IT p...m, TeQ21. This was the first submission for iQor. ...prestigious list of companies," said Vikas Kapoor,...ransforming the way we do business, allowing us to...
(Date:12/1/2009)... ,abominable mystery, and it is a question which h...n did flowering plants evolve and how did they com...n Ecology Letters reveals the evolutionary trigg...ajor competitive advantage over rival species, lea...he study, by Dr Tim Brodribb and Dr Taylor Field ...
Breaking Biology News(10 mins):Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 2Yehezkel Ben-Ari, winner of the 2009 INSERM Grand Prix 3iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2How did flowering plants evolve to dominate Earth? 2Regular Yoga May Improve Eating Habits 55565 1Regular Yoga May Improve Eating Habits 55565 2Another Report Finds Swine Flu Targeting the Young 55562 1Another Report Finds Swine Flu Targeting the Young 55562 2Another Report Finds Swine Flu Targeting the Young 55562 3ThromboGenics NV Announces Business Update and Half Year Results 2009 13723 1ThromboGenics NV Announces Business Update and Half Year Results 2009 13723 2ThromboGenics NV Announces Business Update and Half Year Results 2009 13723 3ThromboGenics NV Announces Business Update and Half Year Results 2009 13723 4ThromboGenics NV Announces Business Update and Half Year Results 2009 13723 5ThromboGenics NV Announces Business Update and Half Year Results 2009 13723 6ThromboGenics NV Announces Business Update and Half Year Results 2009 13723 7ThromboGenics NV Announces Business Update and Half Year Results 2009 13723 8ThromboGenics NV Announces Business Update and Half Year Results 2009 13723 9ThromboGenics NV Announces Business Update and Half Year Results 2009 13723 10ThromboGenics NV Announces Business Update and Half Year Results 2009 13723 11ThromboGenics NV Announces Business Update and Half Year Results 2009 13723 12ThromboGenics NV Announces Business Update and Half Year Results 2009 13723 13ThromboGenics NV Announces Business Update and Half Year Results 2009 13723 14ThromboGenics NV Announces Business Update and Half Year Results 2009 13723 15
...Two peas in a pod may not be so friendly when plan...lant, once separated may treat the former conjoine...ate researcher. , "We were looking at how plants d...ther roots for limited resources," says Dr. Omer F...here is no reason for roots to fight if they belon...
...Restoring the rich diversity of trees that once ch...t gets a helping hand from native birds and bats. ... a question ecologists from the University of Illi...ities are about to find out by setting up essentia...te of Veracruz. , Henry Howe, a noted authority in...
...Turning plants such as corn, soybeans and sunflowe...ing ethanol or biodiesel generates, according to a...ia-Berkeley study. , "There is just no energy ben... David Pimentel, professor of ecology and agricult...ble." , Pimentel and Tad W. Patzek, professor of c...
Other Biology News:Plants discriminate between self and non self 2Birds and bats sow tropical seeds 2Birds and bats sow tropical seeds 3Ethanol and biodiesel from crops not worth the energy 2
...highly efficient transfer of functional proteins t...ection, with PULSin Protein & Antibody Delivery Re...in cells can be controlled, even lethal proteins c...d protein localization studies can now be easily p...
DNA COATING SOLUTION from Pierce Biotechnology, Inc.
...he next frontier of cell-based High Content Screen...e drug discovery process will benefit from the int...tions systems and Cellomics‘ HCS technology,...he sub-cellular level. The integration of these sy...
RC DC Protein Assay Reagents Package from Bio-Rad
Biology Products: